Investor Readiness | Biotechnology
Further development of the business model based on the development of medical polymers for pharmaceutical and biotechnology companies with the goal of investor readiness.
-
Client
University spin-off (DE)
-
Branch
Biotechnology
-
Tags
Biotechnology, Investor Readiness, white ip | Business Solutions
The goals of the cooperation with the university biotechnology spin-off were the further development and elaboration of the business model up to investor readiness.
For an overview of the liquidity of the business project and to determine the capital requirements, a financial plan, profitability calculation and product calculation were to be carried out.
Conducting a market analysis enabled the business model to be sharpened. The resulting overview of the market in the pharmaceutical and biotechnology sector enables a focused orientation of the business model. Based on this, a viable business plan was developed. The next step was the development of turnover scenarios and their effects on the business model, as well as the preparation of the financial planning and profitability calculation.
Combining the business plan and market knowledge with the developed financial planning and product calculation, a solid strategic planning and communication basis was created.
The information was prepared in an investor-friendly way as part of the creation of a pitch deck and will be used by the start-up to find investors.